ConductScience.org, home

Paper984038

Effects of single and combined chemotherapeutic agents on hemopoietic stem cells in mice.

Jenkins VK and 2 others. Am J Hematol, 1976. Cited by 10 papers, by iCite.

Cite this record

ConductScience Library. Effects of single and combined chemotherapeutic agents on hemopoietic stem cells in mice. Papers, record 984038. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/984038

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of single and combined chemotherapeutic agents on hemopoietic stem cells in mice.
PubMed
Journal
Am J Hematol
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.45
iCite
Revised in PubMed
2019-08-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jenkins VKV K
2Costanzi JJJ J
3Ellis HNH N

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Hematopoietic Stem CellsMajor topic
HydrocortisoneMajor topic
MechlorethamineMajor topic
ProcarbazineMajor topic
VincristineMajor topic
Animals
Clone Cells
Drug Evaluation, Preclinical
Drug Therapy, Combination
Female
Male
Mice
Mice, Inbred C57BL
Spleen

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
8258193Assessing permanent damage to primitive hematopoietic stem cells after chemotherapy using the competitive repopulation assay.Cancer Chemother Pharmacol1993https://conductscience.org/library/papers/8258193PubMed
8157470Effects of diflubenzuron and clanfenur on mouse bone marrow cells.Invest New Drugs1993https://conductscience.org/library/papers/8157470PubMed
6277616Assessment of myelotoxicity caused by environmental chemicals.Environ Health Perspect1982https://conductscience.org/library/papers/6277616PubMed
497405Tolerance of hemopoiesis for repeated cytotoxic drug therapy.Blut1979https://conductscience.org/library/papers/497405PubMed
455576Some effects of chemotherapeutic drugs on bone marrow stem cells. II. Effect on non-Hodgkin lymphoma chemotherapy on various hemopoietic compartments of the mouse.Cancer Chemother Pharmacol1979https://conductscience.org/library/papers/455576PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/984038

GET https://conductscience.org/api/papers/v1/984038/authors